Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Clinical trial NCT04210037 · TERMINATED
Trial details
- NCT number
- NCT04210037
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-20
- Primary completion
- 2021-08-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.